Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:49 PM
Ignite Modification Date:
2025-12-24 @ 11:49 PM
NCT ID:
NCT00582751
Eligibility Criteria:
Inclusion Criteria:
* Registered and being treated on one of the following therapeutic protocols:
06-043, 07-052, 07-057, 07-112, 07-116, 08-093, and 08-054
* Have at least one measurable lesion\* as per RECIST criteria situated in lung, liver or lymph node meeting RECIST criteria noted on a baseline CT scan.
* Baseline\*\* and at least one follow-up CT scan to likely to be obtained at an MSKCC facility
* All patients must be \> or = to 18 years old
* The measurable lesions are metastatic in the liver, lung and lymph nodes. The algorithms do not distinguish between primary and metastatic disease, therefore, in selected cases, a primary lesion such as in the liver or lung may also be assessed.
* Baseline CT are prefer but if not able to obtain for volumetric reconstructions follow up studies will still be use for other objectives if the study.
Exclusion Criteria:
* Pregnant or lactating women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00582751
Study Brief:
Protocol Section:
NCT00582751